SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4 + T-cells

Benjamin Descours, Alexandra Cribier, Christine Chable-Bessia, Diana Ayinde, Gillian Rice, Yanick Crow, Ahmad Yatim, Olivier Schwartz, Nadine Laguette, Monsef Benkirane

    Research output: Contribution to journalArticlepeer-review


    Background: Quiescent CD4 + T lymphocytes are highly refractory to HIV-1 infection due to a block at reverse transcription.Results: Examination of SAMHD1 expression in peripheral blood lymphocytes shows that SAMHD1 is expressed in both CD4+ and CD8+ T cells at levels comparable to those found in myeloid cells. Treatment of CD4+ T cells with Virus-Like Particles (VLP) containing Vpx results in the loss of SAMHD1 expression that correlates with an increased permissiveness to HIV-1 infection and accumulation of reverse transcribed viral DNA without promoting transcription from the viral LTR. Importantly, CD4 + T-cells from patients with Aicardi-Goutières Syndrome harboring mutation in the SAMHD1 gene display an increased susceptibility to HIV-1 infection that is not further enhanced by VLP-Vpx-treatment.Conclusion: Here, we identified SAMHD1 as the restriction factor preventing efficient viral DNA synthesis in non-cycling resting CD4 + T-cells. These results highlight the crucial role of SAMHD1 in mediating restriction of HIV-1 infection in quiescent CD4 + T-cells and could impact our understanding of HIV-1 mediated CD4 + T-cell depletion and establishment of the viral reservoir, two of the HIV/AIDS hallmarks. © 2012 Descours et al.; licensee BioMed Central Ltd.
    Original languageEnglish
    Article number87
    Publication statusPublished - 23 Oct 2012


    • HIV-1
    • Quiescent CD4 + T-cell
    • Restriction
    • Reverse transcription
    • SAMHD1


    Dive into the research topics of 'SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4 + T-cells'. Together they form a unique fingerprint.

    Cite this